These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 76798)

  • 1. Long-term transfer-factor treatment for multiple sclerosis.
    Fog T; Pedersen L; Raun NE; Kam-Hansen S; Mellerup E; Platz P; Ryder LP; Jakobsen BK; Grob P
    Lancet; 1978 Apr; 1(8069):851-3. PubMed ID: 76798
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Transfer factor in treatment of multiple sclerosis.
    Basten A; McLeod JG; Pollard JD; Walsh JC; Stewart GJ; Garrick R; Frith JA; Van Der Brink CM
    Lancet; 1980 Nov; 2(8201):931-4. PubMed ID: 6107585
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Transfer factor treatment of patients with multuple sclerosis. I. Preliminary report of changes in immunological parameters.
    Jersild C; Platz P; Thomsen M; Dupont B; Svejgaard A; Ciongoli AK; Fog T; Grob P
    Scand J Immunol; 1976; 5(1-2):141-8. PubMed ID: 178047
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A double-blind trial of transfer factor vs placebo in multiple sclerosis patients.
    Collins RC; Espinoza LR; Plank CR; Ebers GC; Rosenberg RA; Zabriskie JB
    Clin Exp Immunol; 1978 Jul; 33(1):1-11. PubMed ID: 361313
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cell mediated immunity to viral antigens in multiple sclerosis.
    Zabriskie JB; Espinoza LR; Plank CR; Collins RC
    Acta Neurol Scand Suppl; 1977; 63():239-51. PubMed ID: 265669
    [No Abstract]   [Full Text] [Related]  

  • 6. Lymphocyte stimulation in multiple sclerosis patients untreated and treated with transfer factor. Long-term studies on the effect of different stimulants on myo-(2-3H)inositol incorporation into phosphatidylinositol of lymphocytes.
    Offner H; Raun NE; Konat G; Fog T; Clausen J
    Acta Neurol Scand; 1977 Dec; 56(6):465-74. PubMed ID: 605771
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Viral antibodies in multiple sclerosis.
    Norrby E
    Prog Med Virol; 1978; 24():1-39. PubMed ID: 704893
    [No Abstract]   [Full Text] [Related]  

  • 8. Transfer-factor therapy in multiple sclerosis.
    Behan PO; Durward WF; Melville ID; McGeorge AP; Behan WM
    Lancet; 1976 May; 1(7967):988-90. PubMed ID: 57441
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cell-mediated immunity to measles virus in multiple sclerosis: correlation with disability.
    Symington GR; Mackay IR
    Neurology; 1978 Feb; 28(2):109-12. PubMed ID: 202889
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Current problems in multiple sclerosis (immunogenetic aspect) (review of the literature)].
    Khondkarian OA; Zavalishin IA
    Zh Nevropatol Psikhiatr Im S S Korsakova; 1978; 78(2):292-300. PubMed ID: 76384
    [No Abstract]   [Full Text] [Related]  

  • 11. Interferon-alpha and transfer factor in the treatment of multiple sclerosis: a double-blind, placebo-controlled trial. AUSTIMS Research Group.
    J Neurol Neurosurg Psychiatry; 1989 May; 52(5):566-74. PubMed ID: 2659737
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cell-mediated immunity in multiple sclerosis.
    Espinoza LR; Ebers G; Mountcastle W; Zabriskie JB
    Acta Neurol Scand Suppl; 1977; 63():123-31. PubMed ID: 265663
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Letter: Transfer factor in multiple sclerosis.
    Lancet; 1976 Jul; 2(7976):99-100. PubMed ID: 59180
    [No Abstract]   [Full Text] [Related]  

  • 14. Lymphocyte agglutination with paramyxovirus antigens in multiple sclerosis.
    Utermohlen V; Levine J; Ginsparg M
    Clin Immunol Immunopathol; 1978 Feb; 9(2):248-52. PubMed ID: 201412
    [No Abstract]   [Full Text] [Related]  

  • 15. Letter: Lymphocyte agglutination in multiple sclerosis.
    Utermohlen V; Levine J; Ginsparg M
    Lancet; 1975 Oct; 2(7938):772. PubMed ID: 52801
    [No Abstract]   [Full Text] [Related]  

  • 16. Lymphocyte adherence in multiple sclerosis: lack of virus specificity.
    Dore-Duffy P; Zurier RB
    Cell Immunol; 1983 Apr; 77(2):215-21. PubMed ID: 6303601
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Lymphocyte stimulation with measles antigen in multiple sclerosis.
    Knowles M; Saunders M
    Neurology; 1970 Jul; 20(7):700-2. PubMed ID: 5463539
    [No Abstract]   [Full Text] [Related]  

  • 18. [Lymphocyte stimulation tests using measles and distemper virus antigens in the diagnosis of multiple sclerosis].
    Wajgt A; Wiktorowicz K
    Neurol Neurochir Pol; 1975; 9(2):179-84. PubMed ID: 50570
    [No Abstract]   [Full Text] [Related]  

  • 19. Transfer factor treatment of multiple sclerosis. A pilot study.
    Jersild C; Platz P; Svejgaard A; Pedersen L; Kam-Hansen S; Raun N; Mellerup E; Jacobsen B; Linnemann F; Westh P
    Acta Neurol Scand Suppl; 1977; 63():253-64. PubMed ID: 322441
    [No Abstract]   [Full Text] [Related]  

  • 20. Transfer factor. General aspects.
    Grob PJ
    Acta Neurol Scand Suppl; 1977; 63():217-26. PubMed ID: 322440
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.